醫療保健分析測試服務市場規模、佔有率、成長分析（按類型、最終用戶、地區）- 產業預測，2024-2031年

Healthcare Analytical Testing Services Market Size, Share, Growth Analysis, By Type, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月09日 | 出版商:

SkyQuest | 英文 168 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球醫療保健分析測試服務市場規模約66.5億美元，從2023年的73.9億美元上升，預測期間（2024-2031年）年複合成長率為11.2%，預計2031年將達155.5億美元。

市場成長是由幾個關鍵因素推動的，包括需要分析測試的臨床試驗數量的增加、對生物相似藥的日益關注以及製藥公司向外包分析測試服務的顯著轉變。 COVID-19大流行在該市場的擴張中發揮了重要作用。雖然居家訂單和供應鏈中斷最初導致經濟放緩，但對疫苗和治療的迫切需求最終刺激了成長。例如，SGS SA 與AstraZeneca於2020年7月的合作說明了對COVID-19 疫苗AZD1222 非常重要的分析測試服務的需求，以及此類服務如何促進風險降低、加速品質保證，具有確保合規性的能力。技術創新與檢測服務需求增加之間的相關性是顯而易見的，特別是隨著生物相似藥、組合藥物和其他新型療法的出現。此外，競爭加劇、快速進入市場的壓力以及定價挑戰促使製藥公司外包這些測試服務。拓展新市場還需要滿足當地監管要求，導致對特定類型測試的需求增加。隨著對先進、可靠的分析測試的需求持續飆升，預計市場將保持成長軌跡。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東、非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Eurofins Scientific（Luxembourg）
Laboratory Corporation of America Holdings（US）
SGS SA（Switzerland）
Charles River Laboratories（US）
WuXi AppTec Co. Ltd.（China）
Element Materials Technology（UK）
Thermo Fisher Scientific, Inc.（US）
Pace Analytical Services LLC（US）
Intertek Group plc（UK）
IQVIA Inc.（US）
Merck KGaA（Germany）
Source BioScience（UK）
Almac Group（UK）
ICON Plc（Ireland）
Frontage Laboratories, Inc.（US）
STERIS Plc（US）
Sartorius AG（Germany）
ALS Life Science（US）
Syneos Health, INC（US）
Medpace Holdings, Inc.（US）

簡介目錄

Product Code: SQMIG35D2273

Global Healthcare Analytical Testing Services Market size was valued at around USD 6.65 billion in 2022 and is expected to rise from USD 7.39 billion in 2023 to reach a value of USD 15.55 billion by 2031, at a CAGR of 11.2% over the forecast period (2024-2031).

Market growth is driven by several key factors, including a rising number of clinical trials necessitating analytical testing, an increasing focus on biosimilars, and a notable shift towards outsourcing analytical testing services by pharmaceutical companies. The COVID-19 pandemic has played a significant role in this market's expansion; initially causing a slowdown due to stay-at-home orders and disruptions in supply chains, it ultimately spurred growth due to the urgent need for vaccines and treatments. For instance, the collaboration between SGS SA and AstraZeneca in July 2020 exemplified the demand for analytical testing services crucial for the COVID-19 vaccine AZD1222, demonstrating how such services can facilitate risk reduction, accelerate quality assurance, and ensure regulatory compliance. The correlation between innovations and the increased demand for testing services is evident, especially with the advent of biosimilars, combination products, and other novel therapeutics. Furthermore, intensified competition, pressures for quicker market entry, and pricing challenges are driving pharmaceutical firms to outsource these testing services. Expansion into new markets also necessitates meeting local regulatory requirements, resulting in an increased need for specific testing types. As demand for advanced and reliable analytical testing continues to surge, the market is expected to maintain its growth trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Healthcare Analytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Healthcare Analytical Testing Services Market Segmental Analysis

Global Healthcare Analytical Testing Services Market is segmented by Type, End User, and Region. Based on Type, the market is segmented into Medical Device Analytical Testing Services (Extractable and Leachable, Material Characterization, Physical Testing, Bioburden Testing, Sterility Testing, Others), Pharmaceutical Analytical Testing Services (Bioanalytical Testing, Method Development & Validation, Stability Testing, Other Testing Services). Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Hospitals & Clinics, Forensic Labs, Cosmetic & Nutraceutical Companies. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Healthcare Analytical Testing Services Market

The Global Healthcare Analytical Testing Services market is significantly driven by the rising demand for medical testing services, fueled by the surging aging population and the escalating prevalence of chronic diseases. This demand is further amplified by the advent of personalized medicine, which relies on sophisticated diagnostic testing and analytical services for tailored treatment approaches. Additionally, substantial investments from healthcare professionals and the biopharmaceutical sector in enhancing analytical testing capabilities have provided robust momentum to the market. As the necessity for accurate and dependable diagnostic results intensifies, the ongoing expansion and adoption of healthcare testing services are expected to persist, bolstering market growth.

Restraints in the Global Healthcare Analytical Testing Services Market

The Global Healthcare Analytical Testing Services market faces significant restraints primarily due to high pricing and operational complexity. The cost associated with advanced analytical testing, which includes specialized software, sophisticated equipment, and the necessity for expert personnel, can deter small and medium-sized enterprises from investing in these essential services. Moreover, the intricate nature of testing processes compounds the risk of errors and inconsistencies, potentially undermining the integrity of results. This financial and operational burden makes it challenging for smaller firms to compete effectively, ultimately stunting market growth as stakeholders must carefully consider the balance between investment costs and anticipated benefits.

Market Trends of the Global Healthcare Analytical Testing Services Market

The Global Healthcare Analytical Testing Services market is witnessing a significant shift towards outsourcing, driven by cost reduction, technological advancements, and a focus on core competencies among biotechnology and pharmaceutical firms. As companies seek to enhance productivity and streamline operations, they increasingly turn to specialized service providers for analytical testing, allowing them to leverage external expertise and accelerate turnaround times. This trend is expected to grow, fueled by a rising demand for comprehensive analytical testing services that meet strict regulatory standards. Consequently, the outsourcing model is reshaping the market landscape, fostering innovation and efficiency in the healthcare sector.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Case Study Analysis
Regulatory Landscape
Startup Analysis
Technology Analysis
Innovation Matrix
Market Attractiveness Index, 2023

Healthcare Analytical Testing Services Market, By Type

Market Overview
Medical Device Analytical Testing Services
- Extractable and Leachable
- Material Characterization
- Physical Testing
- Bioburden Testing
- Sterility Testing
- Others
Pharmaceutical Analytical Testing Services
- Bioanalytical Testing
- Method Development & Validation
- Stability Testing
- Other Testing Services

Healthcare Analytical Testing Services Market, By End User

Market Overview
Pharmaceutical & Biopharmaceutical Companies
Medical Device Companies
Hospitals & Clinics
Forensic Labs
Cosmetic & Nutraceutical Companies

Healthcare Analytical Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS S.A. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Element Materials Technology (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pace Analytical Services LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IQVIA Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Source BioScience (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Frontage Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STERIS Plc (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ALS Life Science (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health, INC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medpace Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments